# A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

> **NCT00872482** · PHASE2 · TERMINATED · sponsor: **YM BioSciences** · enrollment: 21 (actual)

## Conditions studied

- Metastatic Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** nimotuzumab

## Key facts

- **NCT ID:** NCT00872482
- **Lead sponsor:** YM BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Study closed due to low enrollment
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872482, "A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00872482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*